The FDA has never before limited access to a drug based upon cost considerations. Yet there are some within the agency that are intent on breaking new ground to justify a rationing regime designed to drive down the cost of health care. Avastin is the test case. There is no evidence that the pending show trial will temper their enthusiasm for the rationing scheme.”
One has to wonder what’s next? Will there be rationing for blood pressure medicine? Rationing of dialysis treatment? Are we limiting the rationing to
gender issues age restrictions cost concerns? For the full article on limiting Avastin, go to Exclusive: Sources Confirm FDA Moving Ahead with Rationing.